Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders.
about
Formation of active monomers from tetrameric human beta-tryptaseTryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levelsMolecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular PathologySerum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcomeDiagnosis and treatment of systemic mastocytosis: state of the art.Guideline for acute therapy and management of anaphylaxis: S2 Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Association of German Allergologists (AeDA), the Society of Pediatric Allergy and Environmental MediciMast cell tryptase: a review of its physiology and clinical significance.Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosisMastocytosis: pathology, genetics, and current options for therapy.Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxisThe serum tryptase test: an emerging robust biomarker in clinical hematology.Tryptase as an inflammatory marker in allergic disease and asthma.Current understanding of Kounis syndrome.Current state of biology and diagnosis of clonal mast cell diseases in adults.Immunology and clinical manifestations of non-clonal mast cell activation syndromeIndolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.Serum-tryptase at diagnosis: a novel biomarker improving prognostication in Ph(+) CML.Light is recognized best through darkness: mast cells and Sudden Infant Death Syndrome.Stem cell factor-induced bone marrow mast cell hyperplasia mimicking systemic mastocytosis (SM): histopathologic and morphologic evaluation with special reference to recently established SM-criteria.Hypotensive shock and angio-oedema from angiotensin II receptor blocker: a class effect in spite of tripled tryptase values.Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.
P2860
Q24535233-B0061F94-BA78-46D7-81E8-3E57CD6FF43BQ24679397-686EB7B3-072B-4039-A9A2-2E95CC12E007Q24685914-2E23AFA5-EFBE-4AA4-B399-8E4308CC4B9CQ35025246-AC3DBFB9-9621-4899-8D8C-3E4068617C3BQ35203889-A207A655-7434-423B-A799-7EEE571D7E68Q35777144-DE9F6275-EBA4-4373-98AE-0A392D05FA9BQ35807349-FCE96786-7E83-4679-82AC-2717928DB4B5Q35951578-54805955-F511-4D35-AF32-1A1AE89596CAQ35994902-20DCFDC8-B65C-4651-A8EC-AFC05C7FA0CFQ36007641-D96CBA36-05FE-4772-8F3F-EDA900F30EA2Q36154674-603D5A8C-D3DE-49E1-BB14-50C5B0DC8ED5Q37755301-7D4ABA4C-BBB1-4EF2-822F-C7B40879A746Q37786630-228CDFE3-9887-4D2D-827B-414AF8BB83B3Q38007005-FC6D6E78-EFA7-4842-BC28-78FCC65B2A2FQ38065108-585DFA2E-075F-489D-9784-4E327A29F29EQ40456177-604FB4FE-8B19-4010-B752-83A5B7835F64Q40976858-F11942F3-448D-4E06-A47F-9FDB43BEED93Q41515301-FB2F2A2F-636A-43FD-9D04-0D78D0E55283Q43790344-51A8332C-67FC-400A-8B2A-4AE4CFAC8581Q43987776-3DC1559A-1360-4A0A-B4C2-2D098E6CD054Q46704806-E02880F8-AEC3-4CC2-B69C-915D4A6BC451Q52673481-421A4531-96E2-47F0-85A8-67B0580FD8F3
P2860
Clinical utility of tryptase levels in systemic mastocytosis and associated hematologic disorders.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Clinical utility of tryptase l ...... ociated hematologic disorders.
@ast
Clinical utility of tryptase l ...... ociated hematologic disorders.
@en
Clinical utility of tryptase l ...... ociated hematologic disorders.
@nl
type
label
Clinical utility of tryptase l ...... ociated hematologic disorders.
@ast
Clinical utility of tryptase l ...... ociated hematologic disorders.
@en
Clinical utility of tryptase l ...... ociated hematologic disorders.
@nl
prefLabel
Clinical utility of tryptase l ...... ociated hematologic disorders.
@ast
Clinical utility of tryptase l ...... ociated hematologic disorders.
@en
Clinical utility of tryptase l ...... ociated hematologic disorders.
@nl
P1433
P1476
Clinical utility of tryptase l ...... ociated hematologic disorders.
@en
P2093
Schwartz LB
P304
P356
10.1016/S0145-2126(01)00020-0
P577
2001-07-01T00:00:00Z